Bristol Myers Squibb (BMY) Change in Inventory (2009 - 2026)

Bristol Myers Squibb (BMY) has reported Change in Inventory for 18 consecutive years, with $36.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Inventory rose 1000.0% year-over-year to $36.0 million in Q2 2026; TTM through Jun 2026 was $41.0 million, a 80.29% decrease from a year earlier, with the FY2025 full-year figure at $184.0 million, down 62.14% from the prior year.
• Change in Inventory was $36.0 million for Q2 2026 at Bristol Myers Squibb, up from -$14.0 million in the prior quarter.
• Over five years, Change in Inventory peaked at $282.0 million in Q1 2023 and troughed at -$175.0 million in Q4 2024.
• A 5-year average of $84.0 million and a median of $38.5 million in 2022 frame the typical range for Change in Inventory.
• Across the five-year window, Change in Inventory soared 28300.0% in 2023 and slumped 188.83% in 2024, its largest moves.
• Over 5 years, Change in Inventory stood at $41.0 million in 2022, then jumped by 380.49% to $197.0 million in 2023, then sank by 188.83% to -$175.0 million in 2024, then soared by 59.43% to -$71.0 million in 2025, then soared by 150.7% to $36.0 million in 2026.
• The last three Change in Inventory figures came in at $36.0 million (Q2 2026), -$14.0 million (Q1 2026), and -$71.0 million (Q4 2025), per Business Quant data.